Medtronic (MDT) reported fiscal Q3 non-GAAP earnings Tuesday of $1.39 per diluted share, up from $1.30 a year earlier.
Analysts polled by FactSet expected $1.36.
Revenue for the fiscal quarter ended Jan. 24 was $8.29 billion, up from $8.09 billion a year earlier. Analysts surveyed by FactSet expected $8.33 billion.
For fiscal 2025, the medical devices and technology company maintained its previous non-GAAP EPS guidance of $5.44 to $5.50. Analysts polled by FactSet expect $5.45.
Medtronic also maintained its previous fiscal 2025 revenue growth forecast of 4.75% to 5%. Analysts surveyed by FactSet expect sales of $33.57 billion.
Shares were down nearly 1% in premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。